We signed a collaboration agreement with Aichi Medical University. This collaboration agreement is based on the research theme “Drug Discovery of Spinal Cord Injury with a Neural Regeneration Promoting Effect” by Professor Kosei Takeuchi from Aichi Medical of Medical which was supported by the Drug Discovery Support Network of the Division of Strategic Planning and Evaluation, AMED.
Therapeutics which can be used in the clinical setting based on this research will reduce patients’ paralysis with spinal cord injury caused by various accidents, greatly improve QOL through recovery of motor function, lower the patient care level, which helps patients independent and rehabilitation. Those can extend healthy life expectancy as well. In addition, we aim to build an industrial base for the creation of oligonucleotide therapeutics based on modified nucleic acid technology originated in Japan and to expand oligonucleotide therapeutics overseas.
Please click here for details.